UCB logo

Neurology Strategy Head, Atlanta, GA

UCB

Atlanta, GAHybridPosted 1 day ago$237,000 - $311,000 annually
Full TimeDirector & AboveCommercial & Pharma SalesPharmaceutical
Original posting ↗

Summary

We are looking for a strategic, enterprise-minded Neurology Therapeutic Area Head to lead an integrated customer, specialty, and portfolio agenda across our Neurology indications. This leader will connect global and local priorities, guide portfolio choices, develop a high-performing strategy team, and help unlock the full potential of UCB's Neurology portfolio. This role is based in our Atlanta, GA headquarters.

Job description

About the role

In this Senior Director role, you will lead the Neurology Therapeutic Area within Asset Maximization & Stakeholder Excellence, spanning multiple neurology assets. You will serve as a senior, consistent voice for Neurology across asset, regional, country, and enterprise partners while maintaining clear indication-level ownership. Working closely with Neurology asset teams and Indication Strategy Leads, you will shape an above-indication perspective, align priorities and trade-offs, strengthen external presence, and ensure local teams receive clear, actionable direction.

Who you will work with

You will report to the Head of Asset Maximization & Stakeholder Excellence and lead the Neurology Indication Strategy Leads. Key partners include Neurology asset leadership and PSLTs, Global Customer Strategy, Enterprise Commercial, Global Strategic Planning, Marketing Excellence, Medical, Access, Business Development, regional and country teams, external experts, scientific societies, and patient communities.

What you will do

  • Set the customer and specialty agenda: Build one unified, actionable view of customer needs, tensions, and growth opportunities across Neurology indications, bringing local patient, community, and market insights into global strategy.
  • Shape a coherent Neurology portfolio: Clarify strategic trade-offs, sequencing, dependencies, and synergies across in-market and peri-launch indications while protecting indication ownership.
  • Prioritize shared investment: Recommend allocating shared resources and activities, including congress planning, insight generation, and common investments, to the highest-value opportunities.
  • Accelerate decision-making: Establish clear decision rights and thresholds with asset and AM&SE leadership, so cross-indication decisions are resolved at the right level without creating an additional approval gate.
  • Represent Neurology with one voice: Provide clear, senior Therapeutic Area leadership to local, asset and enterprise partners while maintaining direct access to indication expertise.
  • Strengthen global presence: Advance Therapeutic Area-level scientific and external engagement in alignment with Medical, Access and Patient teams.
  • Enable future growth: Translate market evolution, changing customer needs and pipeline opportunities into portfolio choices and support organic and inorganic growth assessments.
  • Lead and develop leaders: Set shared objectives, coach performance, build capabilities, support career development and succession, and strengthen team connectivity across Neurology.
  • Contribute enterprise leadership: Help shape consistent AM&SE ways of working and increase leadership capacity for portfolio-level priorities.

Minimum Qualifications

  • Bachelor's degree in a scientific or related field.
  • Minimum of 10 years of experience in progressively strategic leadership roles with accountability for influencing business strategy and delivering measurable results.

Preferred Qualifications

  • MBA or other relevant advanced degrees.
  • Significant Neurology experience, including specialty-market dynamics and leadership of product launches from Phase 2/development through post-launch.
  • Demonstrated leadership experience across global and in-country roles, including launch execution, operational leadership, and P&L responsibility.
  • Proven ability to develop portfolio and lifecycle strategies, align senior leaders on priorities and trade-offs, and operate across indication, portfolio, and Therapeutic Area levels.
  • Strong cross-functional leadership across Commercial, Medical, Market Access, Regulatory, and other key functions, including healthcare projects spanning multiple indications and regions.
  • Strong understanding of country-specific regulatory, pricing, reimbursement, and market-access environments.
  • Proven experience leading leaders and teams through both direct and matrix management, including recruitment, performance management, talent development, and succession planning.
  • Demonstrated ability to operate effectively within a complex international matrix and mobilize diverse stakeholders around shared objectives.
  • Excellent written and verbal communication skills, with the ability to distill complex information, influence senior stakeholders, and drive action.

Requirements

  • Bachelor's degree in a scientific or related field
  • Minimum of 10 years of experience in progressively strategic leadership roles with accountability for influencing business strategy and delivering measurable results
  • MBA or other relevant advanced degrees (preferred)
  • Significant Neurology experience, including specialty-market dynamics and leadership of product launches from Phase 2/development through post-launch (preferred)
  • Demonstrated leadership experience across global and in-country roles, including launch execution, operational leadership, and P&L responsibility (preferred)
  • Proven ability to develop portfolio and lifecycle strategies, align senior leaders on priorities and trade-offs, and operate across indication, portfolio, and Therapeutic Area levels (preferred)
  • Strong cross-functional leadership across Commercial, Medical, Market Access, Regulatory, and other key functions (preferred)
  • Strong understanding of country-specific regulatory, pricing, reimbursement, and market-access environments (preferred)
  • Proven experience leading leaders and teams through both direct and matrix management (preferred)
  • Demonstrated ability to operate effectively within a complex international matrix and mobilize diverse stakeholders around shared objectives (preferred)
  • Excellent written and verbal communication skills (preferred)

Benefits

  • Hybrid-first work model
  • 40% office time

Company overview

UCB is a global biopharmaceutical company headquartered in Brussels, Belgium, with a rich history dating back to 1928. The company specializes in developing innovative medicines for severe central nervous system and immunological conditions, with a particular focus on epilepsy, Parkinson's disease, and Crohn's disease. UCB operates in over 40 countries worldwide and employs approximately 9,378 people globally. The company's research and development efforts are centered on creating meaningful solutions that go beyond medicine, driven by patient experiences and scientific innovation. UCB's notable products include Keppra (levetiracetam) for epilepsy, Cimzia (certolizumab pegol) for autoimmune diseases, and Zyrtec (cetirizine) for allergies. With a strong commitment to sustainability and patient-centered care, UCB continues to advance transformative science and technologies to address unmet medical needs and improve the quality of life for patients worldwide.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.